Amgen, Inc. (AMGN) Tops Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $366.29 -1.42%
Revenue Growth %: +2.7%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
UBAB, LOAN, FITB, More
Revenue Growth %: +2.7%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.61, $0.16 better than the analyst estimate of $1.45. Revenue for the quarter came in at $4.05 billion versus the consensus estimate of $3.93 billion.
Reaffirms FY.
For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.
Reaffirms FY.
For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks
- Meritage Hospitality posts Q2 loss amid restructuring charges
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
